The Efficacy and Safety of Temozolomide in Patients With Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: a Multicenter, Single-arm, Phase II Trial
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2016
At a glance
- Drugs Temozolomide (Primary)
- Indications Anaplastic astrocytoma; Oligodendroglioma
- Focus Therapeutic Use
- 22 Apr 2016 Status changed from recruiting to completed.
- 28 Jun 2015 Planned number of patients changed from 39 to 25 as reported by ClinicalTrials.gov record.
- 28 Jun 2015 Planned primary completion date changed to 1 Dec 2015 as reported by ClinicalTrials.gov record.